Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000910680-02-000409
Filing Date
2002-04-11
Accepted
2002-04-11 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMDT. NO. 2 - 12/31/01 d776534_8.txt 10-K/A 278172
3 EX-10.10A LICENSE AGREEMENT d789397_1010a.txt EX-10 45693
4 EX-10.10B AMDT 1 TO LICENSE AGMT d789397_1010b.txt EX-10 3336
5 EX-10.10C AMDT 2 TO LICENSE AGMT d789397_1010c.txt EX-10 3538
6 EX-10.12A LICENSE AGMT d789392_1012a.txt EX-10 53762
7 EX-10.12B SUPPLY AGMT d789392_1012b.txt EX-10 53582
8 EX-10.12C RIGHTS AGMT d789392_1012c.txt EX-10 11838
9 EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP d795131.txt EX-23 711
  Complete submission text file 0000910680-02-000409.txt   453124
Mailing Address 65 LAFAYETTE RD 3RD FLR NORTH HAMPTON NH 03862
Business Address 65 LAFAYETTE RD 3RD FLR NORTH HAMPTON NH 03862 6039648006
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-10581 | Film No.: 02607929
SIC: 2834 Pharmaceutical Preparations